Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

about

Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.Tyrosine Kinase Receptor Expression in Canine Liposarcoma.Injection-Site Sarcoma in a Dog: Clinical and Pathological Findings.

P2860

Q39906311-09938AFC-1153-4B78-89AA-7D0301857F79 Q51435849-388535E4-EA71-4A8C-B95F-3972E26B34FB Q55381309-143D373D-E8F8-4707-814C-0A27E9BB1E57

P2860

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

Item

http://www.wikidata.org/entity/Q54283149

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@en

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@nl

type

Item

label

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@en

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@nl

prefLabel

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@en

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

@nl

P1476

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors

@en

P2093

E Tresoldi

http://www.w3.org/2001/XMLSchema#string

M E Gelain

http://www.w3.org/2001/XMLSchema#string

P Boracchi

http://www.w3.org/2001/XMLSchema#string

P2860

bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

Evaluation of selected growth factor expression in canine spirocercosis (Spirocerca lupi)-associated non-neoplastic nodules and sarcomas.

Angiogenesis in the corpus luteum.

Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.

Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors.

Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.

Hepatic stellate cells: unique characteristics in cell biology and phenotype.

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.

P304

1034-1040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300985815575050

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25795373

http://www.w3.org/2001/XMLSchema#string

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

about

P2860

P2860

Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698